These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7358845)

  • 21. A high molecular weight antigen in Legionnaires' disease bacterium: isolation and partial characterization.
    Johnson W; Elliott JA; Helms CM; Renner ED
    Ann Intern Med; 1979 Apr; 90(4):638-41. PubMed ID: 434650
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interaction between the legionnaires' disease bacterium (Legionella pneumophila) and human alveolar macrophages. Influence of antibody, lymphokines, and hydrocortisone.
    Nash TW; Libby DM; Horwitz MA
    J Clin Invest; 1984 Sep; 74(3):771-82. PubMed ID: 6470140
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Legionella pneumophila pathogenesis and immunity.
    Friedman H; Yamamoto Y; Klein TW
    Semin Pediatr Infect Dis; 2002 Oct; 13(4):273-9. PubMed ID: 12491233
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differentiation of recent and past infections with Legionella pneumophila by determination of specific IgM.
    Krech TU; Krech UH
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 255(1):44-7. PubMed ID: 6637233
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Two sequential layers of antibody-mediated control of Legionella pneumophila infection.
    Weber SS; Stoycheva D; Nimmerjahn F; Oxenius A
    Eur J Immunol; 2019 Sep; 49(9):1415-1420. PubMed ID: 31074841
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dose-response of guinea pigs experimentally infected with aerosols of Legionella pneumophila.
    Berendt RF; Young HW; Allen RG; Knutsen GL
    J Infect Dis; 1980 Feb; 141(2):186-92. PubMed ID: 7365275
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heterogeneity of antibody response in infection with Legionella pneumophila serogroup 1.
    Fallon RJ; Johnston RE
    J Clin Pathol; 1987 May; 40(5):569-72. PubMed ID: 3294909
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interaction of the legionnaires' disease bacterium (Legionella pneumophila) with human phagocytes. II. Antibody promotes binding of L. pneumophila to monocytes but does not inhibit intracellular multiplication.
    Horwitz MA; Silverstein SC
    J Exp Med; 1981 Feb; 153(2):398-406. PubMed ID: 7241049
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Legionella pneumophila serogroup six: isolation from cases of legionellosis, identification by immunofluorescence staining, and immunological response to infection.
    McKinney RM; Wilkinson HW; Sommers HM; Fikes BJ; Sasseville KR; Yungbluth MM; Wolf JS
    J Clin Microbiol; 1980 Sep; 12(3):395-401. PubMed ID: 7012173
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of microagglutination with the indirect immunofluorescence assay for the diagnosis of infection with Legionella pneumophila serogroup 1.
    Bornstein N; Fleurette J
    Eur J Clin Microbiol; 1983 Aug; 2(4):335-9. PubMed ID: 6354714
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Immunopathogenesis of Legionnaires' disease].
    Alim A
    Mikrobiyol Bul; 2004 Jul; 38(3):295-303. PubMed ID: 15490851
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Microbiological aspects of Legionnaires' disease].
    Krech U; Pagon S; Sonnabend W
    Schweiz Med Wochenschr; 1980 Nov; 110(46):1739-45. PubMed ID: 7209465
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A strain of Legionella pneumophila isolated from a pneumonic patient.
    Li ZD; Liu YH; Feng GB; Kang XM; Wu JG
    Chin Med J (Engl); 1986 Jul; 99(7):581-2. PubMed ID: 3100206
    [No Abstract]   [Full Text] [Related]  

  • 34. Legionnaires' Disease: State of the Art Knowledge of Pathogenesis Mechanisms of
    Mondino S; Schmidt S; Rolando M; Escoll P; Gomez-Valero L; Buchrieser C
    Annu Rev Pathol; 2020 Jan; 15():439-466. PubMed ID: 31657966
    [No Abstract]   [Full Text] [Related]  

  • 35. Legionella pneumophila: laboratory diagnosis in developing countries like Pakistan.
    Hafiz S; Hamedani P; Lyall N; Ali J; Memon R; Ali S; Ali M; Ansari M
    J Pak Med Assoc; 1989 Sep; 39(9):229-30. PubMed ID: 2511345
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Isolation of Legionella pneumophila serogroup 1 from human feces with use of amebic cocultures.
    Rowbotham TJ
    Clin Infect Dis; 1998 Feb; 26(2):502-3. PubMed ID: 9502483
    [No Abstract]   [Full Text] [Related]  

  • 37. Serological tests for Legionella pneumophila serogroup 1 infections.
    Taylor AG; Harrison TG
    Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1983 Jul; 255(1):20-6. PubMed ID: 6356710
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serospecificity and opsonic activity of antisera to Legionella pneumophila.
    Johnson W; Pesanti E; Elliott J
    Infect Immun; 1979 Nov; 26(2):698-704. PubMed ID: 121114
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunologic factors affecting the in-vivo and in-vitro survival of the Legionnaires' disease bacterium.
    Arko RJ; Wong KH; Feeley JC
    Ann Intern Med; 1979 Apr; 90(4):680-3. PubMed ID: 373551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of legionella-specific immunity in mice.
    Weber SS; Joller N; Oxenius A
    Methods Mol Biol; 2013; 954():505-20. PubMed ID: 23150417
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.